Immunological mechanisms in pathogenesis of sepsis

International Review of Allergology and Clinical Immunology

Volumn 13, Issue 2-3, 2007, Pages 74-79

  Chudzicka, Aleksandra ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Apoptosis; Cytokines; Sepsis; Toll like receptors

Indexed keywords

BACTERIAL DNA; CYTOKINE; ENDOTOXIN; EXOTOXIN; FLAGELLIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOTEICHOIC ACID; MANNAN; MEMBRANE PROTEIN; PEPTIDOGLYCAN; PROTEIN FOS; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INNATE IMMUNITY; INTENSIVE CARE UNIT; MICROORGANISM DETECTION; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NATURAL KILLER T CELL; NEUTROPHIL; PATHOGENESIS; RECEPTOR BINDING; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE;

EID: 36549087188     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Armstrong L., Medford A.R.L., Hunter K.J. et al.: Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol., 2004, 136, 312-319.
2. Arnolich F., Lopez-Maderrelo D., Codono R. et al.: Interleukine-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin. Exp. Immunol., 2002, 127, 331-336.
3. Bochund P.Y., Calandra T.: Science, medicine, and the future: Pathogenesis of sepsis: new conspect and implications for future treatment. B.M.J., 2003, 326, 262-266.
4. Bone R.C., Grodzin C.J., Balk R.A.: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest, 1997, 112, 235-243.
5. Christman J.W.: Potential treatment of sepsis syndrome with cytokine-specific agents. Chest, 1992, 102, 613-617.
6. Dziubek Z.: Posocznica (wstrza̧s septyczny). In: Choroby zakaźne i pasożytnicz. Z. Dziubek (Ed.). PZWL, 2nd edition, Warsaw, 2000, 293-299.
7. Freitas I., Fernandez-Somoza M., Essenfeld-Sekel E., Cardier J.E.: Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-1 receptor and Fas/FasL, in sepsis. Chest, 2004, 125, 2238-2246.
8. Huizinga J.W., de Haas M., van Oers M.H. et al.: The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. Br. J. Haematol., 1994, 87, 459-463.
9. Kobold A.C.M., Zijlstro J.G., Koene H.R. et al.: Levels of soluble FcγRIII correlate with disease severity in sepsis. Clin. Exp. Immunol., 1998, 114, 220-227.
10. Kübler A.: Sepsa i wstrza̧s septyczny. In: Choroby wewnȩtrzne. A. Szczeklik (Ed.). Medycyna Praktyczna. 1st edition, Cracow, 2006, 2063-2068.
11. Lin R.Y., Astiz M.E., Saxon J.C. et al.: Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD116, CD14 and IL-2R expression. Chest, 1993, 104, 847-853.
12. Monick M.M., Hunninghake G.W.: Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur. Resp. J, 2002, 20, 210-222.
13. Nadel S.: Helping to understand studies examining genetic susceptibility of sepsis. Clin. Exp. Immunol., 2002, 127, 191-192.
14. Nasraway SA: The problems and challenges of immunotherapy in sepsis. Chest, 2003, 123, 451S-459S.
15. Nuijens J.H. Abbink J.J., Wchtfogel Y.T. et al.: Plasma elastase alpha 1-antitripsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J. Lab. Clin. Med., 1992, 119, 159-168.
16. Polska Grupa Robocza ds. Sepsy: Sepsa: Patofizjologia. www.sepsa.pl.
17. Rosenbloon A.J., Pinsly M.R., Bryant J.L. et al.: Leucocyte activation in the peripherial blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukine-6 levels and organ dysfunction. J.A.M.A., 1995, 274, 58-65.
18. Routsi C., Giemarellos-Bourboulis E.J., Autonopoulou A. et al.: Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock? Clin. Exp. Immunol., 2005, 142, 62-67.
19. Scott M.J., Moth J.J., Stegner M.K. et al.: CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent. Clin. Exp. Immunol., 2004, 137, 469-477.
20. Wakefield C.H. Carey P.D., Foulds S. et al.: Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response. Arch. Surg, 1993, 128, 390-395.